Stachyose ameliorates myocardial ischemia-reperfusion injury by inhibiting cardiomyocyte ferroptosis and macrophage pyroptosis

Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113334. doi: 10.1016/j.intimp.2024.113334. Epub 2024 Oct 8.

Abstract

Myocardial ischemia-reperfusion injury (MIRI) is a complex pathological process that results from the restoration of blood flow to ischemic myocardium, leading to a series of detrimental effects including oxidative stress and inflammation. Stachyose, a naturally occurring oligosaccharide found in traditional Chinese medicinal herbs, has been suggested to possess therapeutic properties against various pathological conditions. However, its impact on MIRI and the underlying mechanisms have not been fully elucidated. In this study, we aimed to investigate the therapeutic effects of stachyose on MIRI and to uncover the molecular mechanisms involved. Using both in vivo and in vitro models of MIRI, we evaluated the effects of stachyose on cardiac function and cell death pathways. Our results indicate that stachyose significantly improves cardiac function and reduces infarct size in MIRI mice. Mechanistically, stachyose modulates the ferroptotic pathway in cardiomyocytes by upregulating the expression of glutathione peroxidase 4 (GPX4) and reducing lipid peroxides and iron levels. Additionally, stachyose inhibits the pyroptotic pathway in macrophages by downregulating the expression of NLRP3, gasdermin D (GSMD-N), and cleaved-caspase-1, leading to decreased levels of proinflammatory cytokines interleukin (IL)-1β and IL-18. This study demonstrates that stachyose exerts a protective effect against MIRI by targeting both ferroptosis and pyroptosis pathways, suggesting its potential as a novel therapeutic agent for the treatment of MIRI. Further research is warranted to explore the detailed mechanisms and therapeutic potential of stachyose in clinical settings.

Keywords: Ferroptosis; MIRI; Pyroptosis; Stachyose.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Ferroptosis* / drug effects
  • Gasdermins
  • Macrophages* / drug effects
  • Macrophages* / immunology
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • Myocardial Reperfusion Injury* / drug therapy
  • Myocardial Reperfusion Injury* / metabolism
  • Myocardial Reperfusion Injury* / pathology
  • Myocytes, Cardiac* / drug effects
  • Myocytes, Cardiac* / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Oligosaccharides / pharmacology
  • Oligosaccharides / therapeutic use
  • Phosphate-Binding Proteins / genetics
  • Phosphate-Binding Proteins / metabolism
  • Phospholipid Hydroperoxide Glutathione Peroxidase / metabolism
  • Pyroptosis* / drug effects
  • RAW 264.7 Cells

Substances

  • Oligosaccharides
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Phospholipid Hydroperoxide Glutathione Peroxidase
  • glutathione peroxidase 4, mouse
  • Phosphate-Binding Proteins
  • Nlrp3 protein, mouse
  • Gsdmd protein, mouse
  • Gasdermins